1 | 60-91-3 | 二乙嗪 | diethazine | C18H22N2S
| | |
2 | 508233-74-7 | 沃替西汀 | Vortioxetine | C18H22N2S
| 哌嗪;酰卤;原料药;抗抑郁药;医药原料;化工原料;有机中间体;医药中间体;合成中间体;杂质对照品 | |
3 | 2140316-62-5 | 沃替西汀 D8 | Vortioxetine D8 | C18H22N2S
| | |
4 | 47138-20-5 | (+)-Trimeprazine | (+)-Trimeprazine | C18H22N2S
| | |
5 | 2137588-68-0 | Vortioxetine Imp.J | Vortioxetine Imp.J | C18H22N2S
| 179-沃替西汀 | |
6 | 1815608-51-5 | 沃替西汀杂质S | Vortioxetine impurity S | C18H22N2S
| 杂质对照品;179-沃替西汀 | 杂质对照品;179-沃替西汀 |
7 | | TriMeprazine-d6 HeMitartrate Salt | TriMeprazine-d6 HeMitartrate Salt | C18H22N2S
| Amines;Heterocycles;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals;Sulfur & Selenium Compounds | |
8 | 720670-98-4 | N-benzyl-N'-mesityl-N-methylthiourea | N-benzyl-N'-mesityl-N-methylthiourea | C18H22N2S
| | |
9 | | 3-[phenyl(3-phenylpropyl)amino]propanethioamide | 3-[phenyl(3-phenylpropyl)amino]propanethioamide | C18H22N2S
| | |
10 | 1293489-74-3 | 沃替西汀杂质C | 1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine | C18H22N2S
| 标准品;杂质对照品;对照品-杂质对照品 | |
11 | | N-(2,4-dimethylphenyl)-N'-(4-isopropylphenyl)thiourea | N-(2,4-dimethylphenyl)-N'-(4-isopropylphenyl)thiourea | C18H22N2S
| | |
12 | | 2-(4-phenylphenyl)-2-(thiomorpholin-4-yl)ethan-1-amine | 2-(4-phenylphenyl)-2-(thiomorpholin-4-yl)ethan-1-amine | C18H22N2S
| | |
13 | 47159-85-3 | 2-[(4-methyl-1-piperazinyl)methyl]phenyl phenyl sulfide | 2-[(4-methyl-1-piperazinyl)methyl]phenyl phenyl sulfide | C18H22N2S
| | |
14 | | 2-{4-[(diethylamino)methyl]phenyl}benzene-1-carbothioamide | 2-{4-[(diethylamino)methyl]phenyl}benzene-1-carbothioamide | C18H22N2S
| | |
15 | | 1-butyl-2-phenyl-5,6,7,8-tetrahydro-4(1H)-quinazolinethione | 1-butyl-2-phenyl-5,6,7,8-tetrahydro-4(1H)-quinazolinethione | C18H22N2S
| | |
16 | | 2-{[benzyl(propan-2-yl)amino]methyl}benzene-1-carbothioamide | 2-{[benzyl(propan-2-yl)amino]methyl}benzene-1-carbothioamide | C18H22N2S
| | |
17 | | [3-(1H-indol-1-yl)propyl][1-(5-methylthiophen-2-yl)ethyl]amine | [3-(1H-indol-1-yl)propyl][1-(5-methylthiophen-2-yl)ethyl]amine | C18H22N2S
| | |
18 | | (+)-10-[(R)-3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine | (+)-10-[(R)-3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine | C18H22N2S
| | |
19 | | 2-{4-[(butan-2-ylsulfanyl)methyl]phenyl}benzene-1-carboximidamide | 2-{4-[(butan-2-ylsulfanyl)methyl]phenyl}benzene-1-carboximidamide | C18H22N2S
| | |
20 | 6768-42-9 | 3-dibenzo[b,f][1,4]thiazepin-10(11H)-yl-N,N-dimethyl-1-propanamine | 3-dibenzo[b,f][1,4]thiazepin-10(11H)-yl-N,N-dimethyl-1-propanamine | C18H22N2S
| | |
21 | | 2-(4-{[methyl(propan-2-yl)amino]methyl}phenyl)benzene-1-carbothioamide | 2-(4-{[methyl(propan-2-yl)amino]methyl}phenyl)benzene-1-carbothioamide | C18H22N2S
| | |
22 | | 2-(4-{[(2-methylpropyl)sulfanyl]methyl}phenyl)benzene-1-carboximidamide | 2-(4-{[(2-methylpropyl)sulfanyl]methyl}phenyl)benzene-1-carboximidamide | C18H22N2S
| | |
23 | | N-{[4-(dimethylamino)phenyl]methyl}-3,4-dihydro-2H-1-benzothiopyran-4-amine | N-{[4-(dimethylamino)phenyl]methyl}-3,4-dihydro-2H-1-benzothiopyran-4-amine | C18H22N2S
| | |
24 | | 2-[4-(methylsulfanyl)phenyl]-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-amine | 2-[4-(methylsulfanyl)phenyl]-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-amine | C18H22N2S
| | |
25 | 20977-53-1 | 1-(5,10-Dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-yl)-4-methylpiperazine | 1-(5,10-Dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-yl)-4-methylpiperazine | C18H22N2S
| | |
26 | | 2-(2-methyl-2,3-dihydro-1H-indol-1-yl)-2-[4-(methylsulfanyl)phenyl]ethan-1-amine | 2-(2-methyl-2,3-dihydro-1H-indol-1-yl)-2-[4-(methylsulfanyl)phenyl]ethan-1-amine | C18H22N2S
| | |
27 | | (1-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-1,2,3,4-tetrahydronaphthalen-1-yl)methanamine | (1-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-1,2,3,4-tetrahydronaphthalen-1-yl)methanamine | C18H22N2S
| | |